Amarin Stock News

NEW YORK, Dec. 14, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021, inclusive (the "Class Period") of the important December 23, 2021 lead

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / December 14, 2021 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amarin Corporation Plc (NASDAQ:AMRN) alleging that the Company violated federal securities laws. Class Period: December 5, 2018 to June 21, 2021Lead Plaintiff Deadline: December 23, 2021No obligation or cost to you. Learn more about your recoverable losses in AMRN:https://www.kleinstocklaw.com/pslra-1/amarin-corporation-plc-loss-submission-form?wire=1 Amarin Corporation Plc NEWS - AMRN NEWS CLASS ACTION CASE DETAILS: The filed complaint alleges that Amarin Corporation Plc made materially false and/or misleading statements and/or failed to disclose that: (i) there was an increasingly high risk ..

Amarin Co. plc (NASDAQ:AMRN) reached a new 52-week low during trading on Thursday . The company traded as low as $3.45 and last traded at $3.47, with a volume of 105525 shares traded. The stock had previously closed at $3.61. AMRN has been the subject of a number of research reports. SVB Leerink reiterated a […]

Shares of Amarin Co. plc (NASDAQ:AMRN) dropped 3.5% on Wednesday . The stock traded as low as $3.55 and last traded at $3.56. Approximately 137,368 shares traded hands during trading, a decline of 97% from the average daily volume of 4,624,085 shares. The stock had previously closed at $3.69. AMRN has been the subject of []

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

The biopharma's stock could be near a bottom after last month's double-digit decline.

The biopharma''s stock could be near a bottom after last month''s double-digit decline.

(PR-inside.com) NNEW YORK, NY / ACCESSWIRE / December 7, 2021 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Amarin Corporation Plc ("Amarin") (NASDAQ:AMRN) between December 5, 2018 and June 21, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to: https://www.zlk.com/pslra-1/amarin-corporation-plc-loss-submission-form?prid=21019&wire=5 or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you. Amarin ..

Related Stocks: BBBY , F , AMRN , CZR , WYNN , PFE , ROKU , COIN , NIO , TJX , PLTR , AAL ,

Pomerantz LLP announces that a class action lawsuit has been filed against Amarin Corporation PLC and certain of its officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 21-cv-19911, is on behalf of []

Brokerages predict that Amarin Co. plc (NASDAQ:AMRN) will report $159.26 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Amarins earnings, with estimates ranging from $139.60 million to $192.80 million. Amarin posted sales of $167.25 million in the same quarter last year, which suggests a negative year []

Here are three penny stocks to add to your watchlist right now The post Are These Penny Stocks Worth Buying Right Now Or Not? appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

Here are three penny stocks to add to your watchlist right now The post Are These Penny Stocks Worth Buying Right Now Or Not? appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

Equities research analysts expect Amarin Co. plc (NASDAQ:AMRN) to report $0.01 earnings per share for the current quarter, according to Zacks. Six analysts have made estimates for Amarins earnings, with the highest EPS estimate coming in at $0.02 and the lowest estimate coming in at $0.00. Amarin reported earnings per share of $0.04 during the []